Northwestern University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Northwestern University sits in the top decile of US sponsors by registered trial count (#23 of 15,742 sponsors by registered trial count).

1,209 total trials 187 currently recruiting 767 completed early-phase tilt top decile by trial count

Northwestern University: 1,209 sponsored US clinical trials, 187 recruiting.

Northwestern University sponsors 1,209 registered US clinical trials on ClinicalTrials.gov, 187 of them currently recruiting, and 767 completed. 114 of these trials are in Phase 3-4 (later-stage) and 295 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 11 trials.

Top-decile sponsor footprint

Northwestern University ranks in the top decile of sponsors by registered trial count (#23 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 50/100

767 of 912 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (84.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,209 total, page 19 of 25

COMPLETED NA

Inpatient Obesity Intervention With Phone Follow-up

NCT01920620

COMPLETED NA

Botox and Suction-Curettage for Treatment of Excessive Underarm Sweating (Axillary Hyperhidrosis)

NCT01274611

COMPLETED Phase 2

Improving Platelet Activity for Cerebral Hemorrhage Treatment - DDAVP Proof of Concept

NCT00961532

TERMINATED NA

Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Receiving Paclitaxel

NCT01243541

COMPLETED NA

Tissue Expander Breast Reconstruction Study on Breast Volume and Shape Change

NCT01222390

COMPLETED NA

Lidocaine and Outpatient Gynecologic Laparoscopy

NCT01250002

COMPLETED Phase 4

The Use of Bupivacaine and Ropivacaine for Sciatic Nerve Block

NCT01272921

TERMINATED Phase 2

A Proposal to Test the Efficacy and Tolerability of Bortezomib in Pulmonary Chronic GVHD

NCT01163786

COMPLETED Early Phase 1

African American Community Health Project on Cardiovascular Disease

NCT01335022

COMPLETED Phase 2

Effect of Milnacipran in Chronic Neuropathic Low Back Pain

NCT01225068

COMPLETED NA

Enhanced Spanish Drug Label Study to Promote Patient Understanding and Use

NCT01200849

COMPLETED

A2ALL-Patients Safety System Improvements in Living Donor Liver Transplantation

NCT02073435

COMPLETED NA

Cryolipolysis and Subcision for Treatment of Cellulite

NCT01209767

COMPLETED NA

Text Messaging and Atopic Dermatitis

NCT01216059

TERMINATED NA

Use of Dexmedetomidine for Deep Sedation in Patients Undergoing Outpatient Hysteroscopic Surgery

NCT01337739

COMPLETED NA

Pre Operative Transversus Abdominis Plane Block Laparoscopic Gynecological Surgery

NCT01075074

COMPLETED NA

Fractional Laser and Ultrasound for Striae Distensae

NCT01186848

COMPLETED NA

Transrectal NOTES Appendectomy - Feasibility Study

NCT01189916

COMPLETED Phase 1

An Interactive Informed Consent and Education Program for Pregnant Women

NCT01176019

COMPLETED NA

Assessing and Improving Patient Knowledge About Keloid Scars (Keloids)

NCT01176877

TERMINATED NA

SNAP VS BIS(OAA/S) Scale During a Sedation Regimen With and Without Ketamine

NCT01250418

COMPLETED NA

Per-Oral Endoscopic Esophagomyotomy (POEM)

NCT01635374

COMPLETED NA

Evaluation of a Simulation Training Tool to Identify Lesions Requiring Further Screening for Melanoma

NCT01191294

COMPLETED NA

Paracervical Block Before Intrauterine Device (IUD) Insertion

NCT01207401

TERMINATED NA

Effects of Analgesic Techniques on Duration of Labor for Induction Patients

NCT01982851

TERMINATED Phase 1

A Pilot Study to Assess the Safety and Efficacy of Alefacept in de Novo Kidney Transplant Recipients

NCT01163799

TERMINATED NA

Effects of Analgesic Techniques on Duration of Spontaneously Laboring Patients

NCT01982838

COMPLETED Phase 2

Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas

NCT01125046

COMPLETED Phase 3

Ranolazine and Pulmonary Hypertension

NCT01174173

COMPLETED Phase 2

Comprehensive Evaluation of Ischemic Heart Disease Using MRI

NCT01234870

COMPLETED NA

Genetic Screening for Filaggrin Mutation in Atopic Dermatitis and Ichthyosis Vulgaris in the African American Population

NCT01016106

COMPLETED NA

IV Lidocaine on Postoperative Pain and QOR on Morbid Obese Patients Undergoing Bypass Surgery

NCT01180660

COMPLETED Phase 2

Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1

NCT00993148

COMPLETED Phase 1

Tolerability Study of the Application of a 3M Microstructure Transdermal System

NCT01257763

COMPLETED NA

Cooling Pillow for Atopic Dermatitis

NCT01132651

COMPLETED

Chemokine Mechanisms in Chronic Pelvic Pain

NCT01676857

COMPLETED NA

Melanin Index in Those With Fitzpatrick Skin Phototypes I-VI

NCT01124513

COMPLETED

Occult Paroxysmal Atrial Fibrillation in Patients With Non-cardioembolic Ischemic Stroke of Determined Mechanism

NCT01410396

COMPLETED Phase 2

Low-Literacy Physician-Patient Intervention Promoting Colorectal Cancer Screening

NCT01103479

COMPLETED NA

Dignity Therapy in mCRC to Increase Peaceful Awareness & Impact Goals of Care Decision-Making

NCT01074385

COMPLETED NA

Improving Patient Understanding of Preeclampsia

NCT01119183

COMPLETED Phase 1

E-health Intervention for Cancer Survivors

NCT01114802

COMPLETED NA

Transversus Abdominis Plane (TAP) Block Laparoscopic Hysterectomy

NCT01074229

COMPLETED

Comparison of Two Radial Head Implants

NCT01269840

COMPLETED NA

Electronic Tools to Assist With Identification of and Counseling for Overweight Patients

NCT00973661

COMPLETED NA

Multifactorial Approach to Emergent Cerclage

NCT01114516

COMPLETED NA

The Effect of Pre-Operative Transversus Abdominis Plane (TAP) Block in the Post Operative Opioid Consumption in Morbid Obese Patients Undergoing Laparoscopic Gastric Bypass Surgery: A Prospective,Randomized, Blinded Study

NCT01075087

TERMINATED NA

Analgesic Effect of Ketamine in Patients Undergoing Hysteroscopic Endometrial Thermal Ablation Surgery

NCT01106846

COMPLETED NA

Effectiveness of Video System in Improving Learning of Tracheal Intubation Using Standard Laryngoscopy Among Novices

NCT01080118

COMPLETED NA

A Comparison of Desflurane vs. Sevoflurane and the Time to Awakening and the Incidence and Severity of Cough

NCT01202162

← Previous Page 19 of 25 Next →

Phase Distribution

PhaseTrial count
Phase 1 132
Phase 2 163
Phase 3 36
Phase 4 78

What is open in the Northwestern University pipeline

187 recruiting of 1,209 indexed (15% open); 767 completed (63%).

Phase mix: 114 late (III/IV) vs 295 early (I/II) (early-phase heavy).

Top condition: Depression (11 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Northwestern University: open-pipeline peers nationwide

Peers matched on 1,209 registered trials and 15% open enrollment, not the therapeutic-area sidebar.

Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 12%14%16%18%20% Total trials Recruiting share Northwestern UniversityEmory UniversityUniversity of PittsburghNYU Langone HealthUniversity of Alabama at BirminghamBrigham and Women's HospitalIncyte CorporationNationwide Children's HospitalUniversity of Michigan Rogel Cancer Center
Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Northwestern University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,209 trials (± recruiting share)

Sponsors near 15% open enrollment (± trial volume)

What to do with this Northwestern University page

1,209 registered trials is a research-attention snapshot, not an endorsement of Northwestern University or any single study.

  • 187 of Northwestern University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Depression is the condition Northwestern University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Northwestern University pipeline card: 1,209 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.